That has nothing to do with the contract being canceled or not. Terminating the contract is an affirmative act and it would be a material event.
Instead they created a new contract with Congnate for the manufacture of DCVax Direct, thr links are in my earlier post with a complete explanation and quotes from the relevant contracts.
The reality of it, and I know this for certain as a knowledgeable person in this field, the original contract for DCVax-L continues to be the governing for the relationship with that matter; there is a new contract for DCVax Direct which the language in your quotes is not really about; and lastly, those contracts are about an ongoing relationship, but the DCVax-L contract says it is not terminated until the LATER of 7 years after it was signed or DCVax-L has been license for commercial sales for 5 years.
At that time, under this contract, the parties would still need to decide the necessary terms for commercial production.
Additionally the language in the annual financials is very clear on this point: while the company would prefer to do everything out of Sawston, this may not be possible for regulatory and practical reasons and they continue to have relationships with Cognate, and Fraunhofer if they need them.
The key takeaway is that despite the propagated view by certain interests on this board that Cognate is out of the picture and no contracts exist with them, this is very much not correct and is literally a lie.
Market Data 
Markets 
AI
